Which risks are linked to Fliban 100 Mg ?

Fliban 100 mg contains Flibanserin, a medicine used to treat acquired, generalized hypoactive sexual desire disorder (HSDD), primarily in women. It is sometimes called the female libido medication. Although it may help improve sexual desire in eligible women, it has several important risks and side effects. 1. Common side effects Dizziness Sleepiness and fatigue Nausea Dry mouth Insomnia Constipation Anxiety Low blood pressure DailyMed +1 2. Serious health risks Important safety concerns Low blood pressure: Can cause severe dizziness or weakness. Fainting: May occur due to a sudden drop in blood pressure. Excessive sedation: Can affect alertness and coordination. Liver-related risks: People with liver impairment should not take Flibanserin. Drug interactions: Certain antibiotics, antifungals and other medicines can dangerously increase Flibanserin levels. DailyMed +1 3. Alcohol interaction Alcohol can increase the risk of dangerously low blood pressure and fainting. Current US prescribing guidance advises: Wait at least 2 hours after 1–2 standard alcoholic drinks before taking the bedtime dose. Skip the dose if you have consumed 3 or more standard Fliban 100 Mg that evening. Avoid alcohol until the following day after taking Flibanserin. DailyMed +1 4. Who should avoid Fliban 100 mg? People with liver disease. People taking moderate or strong CYP3A4 inhibitor medicines. People allergic to Flibanserin. People who cannot follow the alcohol precautions. 5. Important questions To give you more relevant safety information: Is Fliban 100 mg intended for a woman or a man? Is the purpose to improve sexual desire, libido or sexual performance? Is it being considered for occasional use or daily use? Important: Flibanserin is not an erectile dysfunction medicine and is not approved for enhancing sexual performance in men. It is prescribed for specific cases of low sexual desire in women. ADDYI- flibanserin tablet, film coated +1 You can also consult the official prescribing information for further safety details.

0 Replies:

Leave a Reply

Your email address will not be published. Required fields are marked *